These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 6757715)

  • 21. Heparin is much more than just an anticoagulant.
    Day JR; Landis RC; Taylor KM
    J Cardiothorac Vasc Anesth; 2004 Feb; 18(1):93-100. PubMed ID: 14973810
    [No Abstract]   [Full Text] [Related]  

  • 22. [Problems of blood coagulation. V. Effect of heparin-like anticoagulants on the first phase of blood coagulation].
    MARBET R; WINTERSTEIN A
    Helv Physiol Pharmacol Acta; 1952; 10(4):528-42. PubMed ID: 13044146
    [No Abstract]   [Full Text] [Related]  

  • 23. Interindividual variability of in vitro response to anticoagulants.
    Samama MM
    Thromb Res; 2011 Jan; 127(1):1. PubMed ID: 21075429
    [No Abstract]   [Full Text] [Related]  

  • 24. Inter-individual variability of effect of 7 low molecular weight antithrombin-dependent anticoagulants studied in vitro with calibrated automated thrombography.
    Hacquard M; Perrin J; Lelievre N; Vigneron C; Lecompte T
    Thromb Res; 2011 Jan; 127(1):29-34. PubMed ID: 20850172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anticoagulant properties of heparin fractionated by affinity chromatography on matrix-bound antithrombin iii and by gel filtration.
    Andersson LO; Barrowcliffe TW; Holmer E; Johnson EA; Sims GE
    Thromb Res; 1976 Dec; 9(6):575-83. PubMed ID: 1006626
    [No Abstract]   [Full Text] [Related]  

  • 26. [Influence of nonachlazin, riboxin and isoptin on the blood coagulation system and the anticoagulant effect of heparin].
    Shevchenko LV; Ovchinnikova LK; Zolotukhin SI
    Farmakol Toksikol; 1980; 43(4):389-95. PubMed ID: 7439373
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The antithrombin effect of heparin; role of heparin concentration].
    BURSTEIN M
    C R Seances Soc Biol Fil; 1952 May; 146(9-10):641-2. PubMed ID: 12998196
    [No Abstract]   [Full Text] [Related]  

  • 28. High-activity heparin: chain length, affinity for antithrombin, and anticoagulant activity.
    Radoff S; Danishefsky I
    Arch Biochem Biophys; 1982 Apr; 215(1):163-70. PubMed ID: 7092223
    [No Abstract]   [Full Text] [Related]  

  • 29. Differential effects of direct thrombin inhibitors and antithrombin-dependent anticoagulants on the dynamics of clot formation.
    Young G; Yonekawa KE; Nakagawa PA; Blain RC; Lovejoy AE; Nugent DJ
    Blood Coagul Fibrinolysis; 2007 Mar; 18(2):97-103. PubMed ID: 17287624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Actions and interactions of antithrombin and heparin.
    Rosenberg RD
    N Engl J Med; 1975 Jan; 292(3):146-51. PubMed ID: 127943
    [No Abstract]   [Full Text] [Related]  

  • 31. [Inhibition of plasmatic coagulation: what is new?].
    Schwarz M; Bode C
    Hamostaseologie; 2006 May; 26(2):154-7. PubMed ID: 16676059
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anticoagulant activities and effects on platelets of a heparin fragment with high affinity for antithrombin.
    Holmer E; Lindahl U; Bäckström G; Thunberg L; Sandberg H; Söderström G; Anderson LO
    Thromb Res; 1980 Jun; 18(6):861-9. PubMed ID: 7414566
    [No Abstract]   [Full Text] [Related]  

  • 33. Dermatan sulfate and LMW heparin enhance the anticoagulant action of activated protein C.
    Fernández JA; Petäjä J; Griffin JH
    Thromb Haemost; 1999 Nov; 82(5):1462-8. PubMed ID: 10595639
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anticoagulants and their site of action.
    Haas-Weston CF
    Southwest Med; 1971 Jun; 52(6):119-26. PubMed ID: 5559910
    [No Abstract]   [Full Text] [Related]  

  • 35. Anticoagulant activity and platelet aggregation in blood plasma from rats after intranasal administration of adenosine triphosphate and its complex with heparin.
    Pastorova WE; Lyapina LA; Obergan TY; Shubina TA
    Bull Exp Biol Med; 2008 Sep; 146(3):273-5. PubMed ID: 19240836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heparin affin regulatory peptide modulates the endogenous anticoagulant activity of heparin and heparan sulphate mimetics.
    Mejdoubi-Charef N; Courty J; Sineriz F; Papy-Garcia D; Charef S
    Basic Clin Pharmacol Toxicol; 2012 Nov; 111(5):296-302. PubMed ID: 22672269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Physico-chemical characteristics of heparin in relation to its anticoagulant and anti-hemostatic action].
    Nader HB; Dietrich CP; Straus AH; Takahashi HK
    Rev Bras Biol; 1979 Nov; 39(4):793-816. PubMed ID: 162073
    [No Abstract]   [Full Text] [Related]  

  • 38. Antithrombin in vertebrate species: conservation of the heparin-dependent anticoagulant mechanism.
    Jordan RE
    Arch Biochem Biophys; 1983 Dec; 227(2):587-95. PubMed ID: 6607710
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationships between antithrombin activity, anticoagulant efficacy of heparin therapy and perioperative variables in patients undergoing cardiac surgery requiring cardiopulmonary bypass.
    Muedra V; Bonanad S; Gómez M; Villalonga V; Sánchez F; Llopis JE
    Perfusion; 2011 Nov; 26(6):487-95. PubMed ID: 21665912
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The mechanism of reaction of heparin].
    Stürzebecher J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1977; 104(6):731-9. PubMed ID: 75142
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.